Zymeworks Inc.

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

ZYME$31.46+2.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Changes in Stockholders’ Equity

Condensed Consolidated Statement of Changes in Stockholders’ Equity

(In thousands except share data) (unaudited)

Preferred stock · Exchangeable shares · Common stock · Accumulateddeficit · Accumulatedothercomprehensive loss · Additionalpaid-incapital · Totalstockholders’equity
Shares · Amount · Shares · Amount · Shares · Amount
Balance at January 1, 2026	1	$—	553,184	$7,938	74,638,413	$1,105,176	$(953,160)	$(6,079)	$114,626	$268,501
Issuance of common stock on exercise of options	—	—	—	—	839,943	14,117	—	—	(5,400)	8,717
Issuance of common stock through employee stock purchase plan	—	—	—	—	58,313	649	—	—	—	649
Issuance of common stock upon vesting of restricted stock units (“RSUs”)	—	—	—	—	758,886	8,578	—	—	(8,578)	—
Issuance of common stock for retracted exchangeable shares	—	—	(2,300)	(33)	2,300	33	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	6,882	6,882
Purchase and retirement of common stock	—	—	—	—	(3,195,166)	—	(76,151)	—	—	(76,151)
Excise tax on purchase of common stock	—	—	—	—	—	—	(361)	—	—	(361)
Net loss	—	—	—	—	—	—	(44,162)	—	—	(44,162)
Other comprehensive loss	—	—	—	—	—	—	—	(486)	—	(486)
Balance at March 31, 2026	1	$—	550,884	$7,905	73,102,689	$1,128,553	$(1,073,834)	$(6,565)	$107,530	$163,589
Issuance of common stock on exercise of options	—	—	—	—	279,076	4,948	—	—	(1,741)	3,207
Issuance of common stock upon vesting of RSUs	—	—	—	—	37,666	445	—	—	(445)	—
Issuance of common stock for retracted exchangeable shares	—	—	(884)	(13)	884	13	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	11,106	11,106
Purchase and retirement of common stock	—	—	—	—	(2,008,243)	—	(51,949)	—	—	(51,949)
Excise tax on purchase of common stock	—	—	—	—	—	—	(436)	—	—	(436)
Net loss	—	—	—	—	—	—	(45,019)	—	—	(45,019)
Other comprehensive loss	—	—	—	—	—	—	—	(129)	—	(129)
Balance at June 30, 2026	1	$—	550,000	$7,892	71,412,072	$1,133,959	$(1,171,238)	$(6,694)	$116,450	$80,369
Issuance of common stock on exercise of options	—	—	—	—	258,795	4,478	—	—	(1,612)	2,866
Issuance of common stock through employee stock purchase plan	—	—	—	—	29,279	897	—	—	—	897
Issuance of common stock for retracted exchangeable shares	—	—	(11,110)	(159)	11,110	159	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	12,378	12,378
Purchase and retirement of common stock	—	—	—	—	(534,381)	—	(11,992)	—	—	(11,992)
Net income	—	—	—	—	—	—	173,700	—	—	173,700
Other comprehensive income	—	—	—	—	—	—	—	35	—	35
Balance at September 30, 2026	1	$—	538,890	$7,733	71,176,875	$1,139,493	$(1,009,530)	$(6,659)	$127,216	$258,253

Condensed Consolidated Statement of Changes in Stockholders’ Equity

(In thousands except share data) (unaudited)

Preferred stock · Exchangeable shares · Common stock · Accumulateddeficit · Accumulatedothercomprehensiveloss · Additionalpaid-incapital · Totalstockholders’equity
Shares · Amount · Shares · Amount · Shares · Amount
Balance at January 1, 2025	1	$—	570,637	$8,188	68,964,319	$1,015,618	$(830,335)	$(6,952)	$152,249	$338,768
Issuance of common stock on exercise of options	—	—	—	—	84,863	1,208	—	—	(437)	771
Issuance of common stock through employee stock purchase plan	—	—	—	—	74,274	724	—	—	—	724
Issuance of common stock upon vesting of RSUs	—	—	—	—	460,620	4,390	—	—	(4,390)	—
Issuance of common stock for retracted exchangeable shares	—	—	(735)	(10)	735	10	—	—	—	—
Stock-based compensation	—	—	—	—	—	—	—	—	6,794	6,794
Net loss	—	—	—	—	—	—	(22,636)	—	—	(22,636)
Other comprehensive income	—	—	—	—	—	—	—	546	—	546
Balance at March 31, 2025	1	$—	569,902	$8,178	69,584,811	$1,021,950	$(852,971)	$(6,406)	$154,216	$324,967
Issuance of common shares on exercise of options	—	—	—	—	174,856	2,267	—	—	(882)	1,385
Issuance of common shares upon exercise of pre-funded warrants	—	—	—	—	5,086,480	49,862	—	—	(49,862)	—
Stock-based compensation	—	—	—	—	—	—	—	—	5,771	5,771
Net income	—	—	—	—	—	—	2,317	—	—	2,317
Other comprehensive income	—	—	—	—	—	—	—	66	—	66
Balance at June 30, 2025	1	$—	569,902	$8,178	74,846,147	$1,074,079	$(850,654)	$(6,340)	$109,243	$334,506
Issuance of common stock on exercise of options	—	—	—	—	840,052	12,695	—	—	(4,131)	8,564
Issuance of common stock through employee stock purchase plan	—	—	—	—	65,702	1,157	—	—	—	1,157
Issuance of common stock for retracted exchangeable shares	—	—	(713)	(10)	713	10	—	—	—	—
Private placement for issuance of common stock	—	—	—	—	415,000	4,988	—	—	—	4,988
Repurchase and retirement of common stock	—	—	—	—	(1,028,333)	—	(16,216)	—	—	(16,216)
Stock-based compensation	—	—	—	—	—	—	—	—	6,377	6,377
Net loss	—	—	—	—	—	—	(19,602)	—	—	(19,602)
Other comprehensive income	—	—	—	—	—	—	—	290	—	290
Balance at September 30, 2025	1	$—	569,189	$8,168	75,139,281	$1,092,929	$(886,472)	$(6,050)	$111,489	$320,064

The accompanying notes are an integral part of these financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.